Medical Management of HIV/AIDS and Key Infections (MMAKI)

Thank you for joining our 2024 conference! We hope to see you again at the UCSF Mission Bay Conference Center on December 11–13, 2025 (virtual option also available).

Please visit our MMAKI course website for more information.

The Medical Management of HIV/AIDS and Key Infections Conference is a continuing medical education (CME) course presented by the Division of HIV, Infectious Diseases & Global Medicine at the University of California, San Francisco – Zuckerberg San Francisco General. Each year, it enrolls and provides CME credits for approximately 300 participants.

Previously known as the Medical Management of HIV/AIDS, the CME course expanded to include hepatitis (MMAH) and, in 2020, added COVID-19, becoming MMAHC. With the rise of mpox, RSV, and flu, we recognize the increasing prevalence of both old and new infectious diseases. Therefore, we are now the Medical Management of HIV/AIDS and Key Infections (MMAKI). It’s the same excellent three-day course with dynamic speakers, comprehensive syllabi, and a thoughtful audience, available both in person and virtually from December 11–13, 2025. Please note that Days 1 and 2 are available both in person and virtually, while Day 3, on December 7th, is entirely virtual.

The symposium provides three full days of focused, topical education and updates on HIV, ART management, HIV dermatology, hepatitis, COVID-19, and key infections for clinicians from around the world. Lectures and workshops are presented by leading clinicians and researchers.

Each year’s agenda reflects recent advances, discoveries, and emergent issues. The agenda is geared toward intermediate to advanced HIV clinicians and ambitious, committed beginning clinicians. Our course is unique in that it provides a “New Clinicians Track” with five additional didactic lectures for beginning clinicians.

The MMAKI CME course is chaired by Division Chief and Professor Diane Havlir, MD; Associate Professor Emeritus Meg Newman, MD; and Professor Annie Luetkemeyer, MD.